Balda AG: Balda AG and Mechatronic AG present newest version of their jointly developed app-controlled drug dispenser

DGAP-Media / 10.02.2016 / 10:01

The Smart Drug Dispenser, which keeps track of tablets, is now 25% smaller.

Paris, February 10, 2016 – As previously reported, patients will soon be

able to dose their drugs via their smartphones. The medical technology

companies Balda AG and Mechatronic AG presented the Smart Drug Dispenser

for the first time at the CPhI Worldwide in Madrid this past October, and

received an innovation award at the Compamed in Düsseldorf the very next

month. The combination of app and easy-to-handle drug dispenser helps

prevent administration errors and thus unnecessary complaints or hospital

stays. They have now further developed the dispenser itself, making it

approximately 25% smaller for even easier handling.

A signal helping patients: The Smart Drug Dispenser makes an important

contribution to therapy safety. The physician or patient enters the number

of pills and the time when the medication is to be taken, via the app. The

device, which easily fits in the palm of your hand, stores the dosage

regimen and dispenses the tablets via the push of a button. The associated

smartphone app gives the user reminders – via text alerts and an acoustic

signal – until the proper dose has been dispensed. This prevents under- or

over dosage. Scientific figures show that this support is dearly needed.

Additionally, via the app, messages regarding missed doses could be sent to

someone supporting the patient.

Forgotten, mistaken or lost – over 50 per cent of medication is not taken

as prescribed. According to studies, one in four patients does not follow

the therapy regimen. Not necessarily on purpose. Surveys show that many

people simply forget to take their drugs. Consequences such as extended

healing processes, secondary diseases and additional trips to the doctor

are not only bothersome for the patients. The costs to the German

healthcare system alone, due to deficient compliance, are conservatively

estimated to be in excess of 10 billion EUR per year.

Christoph Klaus, Head of the Business Unit Balda Healthcare has recognized

the potential of the system: “An ageing population that is also tech-savvy

has a need for modern solutions. The Smart Drug Dispenser is an exciting

product that provides added value for patients, physicians, relatives and

also health insurers”.

Balda AG and Mechatronic AG will present their joint project on 10 and 11

February within the scope of the Pharmapack in Paris. Visitors may test the

Smart Drug Dispenser in Hall 54, booth 818 and see it on display at the

exclusive “Innovations Gallery”.

Photographic material is available via this link:

Contact/Contact Person

Balda AG

Kathrin Wiederrich

Bergkirchener Str. 229

32549 Bad Oeynhausen

Tel: +49 5734 922 2023

Mobil: +49 176 19227157

End of Media Release


Issuer: Balda AG

Key word(s): Health

10.02.2016 Dissemination of a Press Release, transmitted by DGAP – a service

of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at and


Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen


Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604



ISIN: DE0005215107

WKN: 521510

Listed: Regulated Market in Frankfurt (Prime Standard); Regulated

Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,

Munich, Stuttgart

End of News DGAP Media


436065 10.02.2016